About WIDES
The World Interventional & Dry Eye Society: advancing the science, education, and clinical practice of modern dry eye management.
Welcome to WIDES, the World Interventional & Dry Eye Society. WIDES is committed to advancing the science, education, and clinical practice of modern dry eye management.
Over recent years, understanding of Meibomian gland dysfunction (MGD) has evolved considerably, in parallel with the development of non-pharmacological technologies capable of precisely targeting the pathophysiological mechanisms of evaporative dry eye.
This website offers an updated overview of the therapeutic strategies available in 2026, with particular emphasis on the synergistic integration of dry eye drops and modern physical treatments: intense pulsed light, electrical current devices, photobiomodulation, thermotherapies, and radiofrequency.
The concept of Interventional Dry Eye was conceived and developed by WIDES under the chairmanship of Professor Pablo Dighiero.
Through an evidence-based, pathophysiology-driven, and multimodal approach, WIDES supports the integration of innovative technologies into structured clinical practice.
This platform is intended for ophthalmologists and eye care professionals seeking practical, modern, and scientifically robust therapeutic solutions for dry eye disease.
Our mission is to improve clinical outcomes by restoring tear film stability, optimizing glandular function, and re-establishing ocular surface homeostasis.
WIDES invites you to explore the future of dry eye care.
Founder & Chairman
Professor Pablo Dighiero
MD, PhD - Ophthalmologist, Cornea & Ocular Surface Specialist
Professor Pablo Dighiero, MD, PhD, is a French ophthalmologist internationally recognized for his expertise in cornea, ocular surface disease, refractive surgery, and dry eye.
Founder and Chairman of the World Interventional & Dry Eye Society (WIDES) and of the Association of Dry Eye Centers (ACOS), he leads the Dry Eye Institute of Barbizon, where his clinical and scientific work is devoted to the most advanced forms of ocular surface and dry eye care.
His academic path was shaped by an eminent Parisian background at Hotel-Dieu Hospital, where he completed his fellowship in cornea, ocular surface, anterior segment, and refractive surgery, and later served as Assistant Professor in the Department of Cornea and Refractive Surgery. He subsequently became Professor of Ophthalmology at Poitiers University, building a career at the intersection of academic excellence, surgical refinement, and clinical innovation.
Over the years, Professor Dighiero has developed a distinctive vision of dry eye management, grounded in pathophysiology, precision diagnostics, and therapeutic synergy. His work has contributed to the modern understanding of meibomian gland dysfunction, meibography, epithelial OCT, IPL-based strategies, and multimodal non-pharmacological treatment protocols, including the development of the eTAO method for the standardized evaluation and follow-up of dry eye disease.
Through WIDES, he promotes a new international standard of care in Interventional Dry Eye, combining scientific rigor, technological innovation, and highly personalized treatment strategies. His ambition is to offer ophthalmologists, as well as patients from across Europe and beyond, access to a more advanced, structured, and sophisticated approach to dry eye disease and ocular surface restoration.
Strategic Vision
WIDES Goals
- Establish Interventional Dry Eye as a clinical framework. Move ocular surface disease beyond symptomatic management, towards a model that connects disease mechanisms, objective diagnostics, and targeted therapeutic combinations.
- Standardise severity assessment. Promote the eTAO Score as a structured, reproducible metric so that stratification, follow-up, and treatment selection become consistent across practices.
- Advance education and clinical exchange. Bring clinicians, educators, and innovators together through the annual congress, shared protocols, and an international network of practitioners.